Open access

Skin Cancer Screening

Written By

Carolyn J. Heckman, Susan Darlow, Teja Munshi and Clifford Perlis

Submitted: May 8th, 2012 Published: April 17th, 2013

DOI: 10.5772/55243

Chapter metrics overview

1,677 Chapter Downloads

View Full Metrics

1. Introduction

This chapter reviews 1) the incidence, mortality, and risk factors for skin cancer, 2) the efficacy, cost-effectiveness, and frequency of skin cancer screening, 3) behavioral interventions to improve engagement in skin cancer screening, and 4) issues related to screening of special populations.


2. Melanoma and non-melanoma incidence, mortality and risk factors

Skin cancer is the most common cancer in the US, with almost three million individuals being diagnosed annually [1]. Both melanoma and non-melanoma (or keratinocyte) skin cancer (NMSC) incidence rates have been increasing in recent decades [2]-[4]. In 2012, melanoma is predicted to be the fifth most common cancer among US men and the sixth most common cancer among women [2]. Risk factors for melanoma and NMSC include male sex, age over 50 years, personal or family history of melanoma or NMSC, red hair, blue or green eyes, Fitzpatrick skin type I (very fair skin sensitive to ultraviolet radiation [UV]) with freckles, actinic keratosis on the head, familial atypical mole-melanoma syndrome, or numerous (i.e., > 100) moles [2], [5]-[15]. Additionally, many melanomas and NMSCs can be attributed to UV exposure such as via outdoor occupations, one blistering sunburn prior to age 18, multiple sunburns at any age, or indoor tanning [15]-[21].


3. Efficacy of skin cancer screening

During a total cutaneous examination (TCE), the healthcare professional uses observation by sight, sometimes augmented by serial photography and/or dermoscopy to detect not only skin cancer but also risk factors for skin cancer (e.g., actinic keratoses) [22]. Suspicious lesions may then be biopsied and examined histologically. TCE also allows the healthcare professional the opportunity to educate the patient regarding their risk of skin cancer [22]-[24]. Screening of those at high risk for skin cancer detects tumors at an earlier stage when tumors are thinner, resulting in lower mortality rates [25]-[31]. Due to their clinical training and expertise, dermatologists are able to detect melanoma tumors during an early stage of growth, whereas patients may not notice a tumor until it is noticeably thick [32]-[34]. To date there are no major randomized controlled trials assessing the efficacy of TCE, but a case-control study found that melanoma patients who had a TCE in the three years prior to their diagnosis were 14% less likely to have thick melanoma, resulting in 26% fewer deaths [25]. Specificity for detection of melanoma through TCE is comparable to that of other cancer screening tests [35]. Most professional organizations recommend total cutaneous examination (TCE) for high risk individuals [1], [36]-[38], and some recommend population screening [39]; although, in 2009 the US Preventive Services Task Force concluded that there was insufficient evidence to recommend skin cancer screening for the general adult population [40].

Patients and their family/friends are the first to spot half to three quarters of all melanomas [41]-[45]. To perform SSE, individuals are instructed to carefully examine all of their skin for abnormal spots following the “ABCDE” criteria: asymmetry, irregular borders, variation in color, large diameter (i.e., >6mm or a pencil eraser), and evolving (i.e., a changing spot) [46]. Skin self-examination (SSE) is associated with thinner tumors [47], may shorten the time to diagnosis [48], and may reduce melanoma mortality by up to 63% [49]. Both the National Cancer Institute [38] and the American Cancer Society [36] recommend monthly SSE.


4. Cost-effectiveness and frequency of skin cancer screening

Because of its high prevalence, NMSC is among the mostly costly cancers to treat among the Medicare population [50]. SSEs are cost-effective in that people can perform them on their own; however, there is the potential for otherwise unnecessary medical visits. Screening programs with cost ratios less than $50K per year of life saved are said to be cost-effective [51]-[54]. Two studies found that dermatologist skin cancer screening for individuals 50 years of age or older is cost-effective with costs of $10-$16K per quality-adjusted life year [QALY] saved overall and $35K per QALY for biennial screening of siblings of melanoma patients; whereas, annual screening of the general population is not cost-effective [52], [53]. A 1996 Australian study of the cost-effectiveness of every five-year screenings by family practice physicians of men over 50 years of age found a cost-effectiveness of $6.9K per QALY [55]. In comparison, the cost-effectiveness ratios for biennial mammography for women ages 50-69 years and for colorectal cancer screening every five years after age 50 are $30.5K and $47.4K per QALY saved, respectively [51], [54]. With the introduction of the Patient Protection and Affordable Care Act, those previously without health insurance will have access to medical care [56]. In addition, this law will increase the focus on prevention of chronic illnesses such as cancer [57].

Although efficacious and cost-effective, rates of ever having had a TCE are low at approximately 15-17% among US adults [58], [59]. Despite the recommendation from some organizations for monthly SSE, SSE rates are also suboptimal. US and Australian studies conducted from 1991 to 2004 found that only 23-61% of individuals performed SSE at least annually [60]-[66]. A study of Scottish patients also noted that approximately one third of patients did not seek medical attention until more than three months after noticing a worrisome pigmented lesion, potentially contributing to thicker melanomas [67]. Due to the relatively low rates of skin cancer screening, it is important to identify efficacious and cost-effective interventions to increase engagement in screening behavior, particularly among high risk groups such as men 50 years of age and older.


5. Psychosocial barriers to skin cancer screening

Several psychosocial variables have been found to be associated with skin cancer screening. Dermatologists’ main reason for not conducting TCE is patients’ perceived embarrassment or reluctance [68]. An Australian study found that having a TCE in the past three years was associated with having a positive attitude toward skin cancer screening [69]. TCE intentions were higher among first-degree relatives of melanoma patients reporting greater physician and family support and perceiving greater benefits (e.g., to prevent cancer) of and lesser barriers (e.g., not enough time, anxiety) to TCE [70]. Barriers to TCE reported by Australian employees included fear of being diagnosed and difficulty attending appointments during work hours [71]. SSE has been found to be associated with higher SSE self-efficacy (i.e., SSE-related confidence) [72] and perceived benefits of and barriers to SSE [73] among melanoma patients/survivors. Intentions to receive SSE were higher among individuals with higher family support and higher benefits and lower barriers to self-examination [70]. SSE-related benefits were the strongest predictor of SSE among individuals from families with familial atypical multiple mole melanoma [74]. Other barriers to self-detection include limited ability to recall the skin’s appearance and undercounting the number of moles on the skin [75]. Physicians, family, and media may serve as cues to action in skin cancer prevention and detection [76].


6. Prior interventions to increase skin cancer screening

Community and mass media campaigns (e.g., SkinWatch) that have increased TCE have been conducted mostly in Australia [35], [77]. For example, SkinWatch, a three-year Australian rural and regional community-based randomized controlled trial, involved community education (“self-help guide” to skin examination and melanoma risk factors, available in physicians’ waiting rooms), a media campaign (press regarding the program and advertisements), and volunteer recruitment and activities (training of a “Volunteer SkinWatch Coordinator” in each community to serve as liaison between the community and research team). More than 16,000 people attended SkinWatch screening clinics conducted by general practitioners and special screening services [78], [79]. By two years, screening rates almost tripled in intervention communities [35]. Screening attendance was associated with age 40-49 years, fair skin, personal history of skin cancer, concern about a spot or mole, and not having had a recent TCE [80]. Reasons endorsed for failing to attend screening services included a lack of knowledge regarding services, not having time to attend services, and having had a TCE recently [80]. A few studies assessing interventions to increase TCE have found low (2-19%) uptake rates even among high risk populations [28], [81]. On the other hand, a more recent Australian study found that 71% of employees attended a free workplace skin cancer screening [71]. Finally, Manne and colleagues [82] found that a tailored print intervention increased TCE intentions and performance among first degree relatives of melanoma patients.

Interventions that have increased SSE through 1-year follow up among the general population have included in person and telephone approaches, videos, pamphlets, and free TCE [83]-[87]. For high risk populations such as melanoma patients and their family members, two UK and US groups have found success at 3-6 months using Skinsafe, an interactive multimedia intervention including characteristics of skin at risk, early signs of melanoma, personalized risk feedback, and SSE instruction [88], [89]. Other interventions have included the approaches used for general populations as well as personalized risk feedback, diaries and body maps, tailored recommendations and reminders, workbooks, a couple-based approach, guided imagery, and the use of photos of moles [75], [88], [90]-[99]. In general, interventions that have significantly increased skin cancer screening have tended to target high risk populations and be interactive and individually tailored based on personal characteristics, attitudes, and behaviors [92], [94].


7. Special populations

7.1. Older men

It is well-documented that men, particularly those aged 50 years and older, have higher incidence of, as well as morbidity and mortality from melanoma than other demographic groups [1], [100]-[103]. During the past decade, the incidence of thick melanomas (i.e., 4 mm) in the US increased significantly only in men 60 years of age and older [1]. A recent analysis of four phase III trials found that women had a consistent 30% advantage in all aspects of localized melanoma progression, which they attribute to a variety of potential tumor- and host-related biologic sex difference [100]. Studies have found that women are also more likely than men to do SSE [48], [60], [61], [63], [65], [66], [104-[107], intend to do TCE [108], and detect melanomas [42], [44]. Figure 1 shows US TCE rates in 2005 among various demographic groups.

Health interventions targeted specifically to men may benefit from a consideration of masculinity [109]-[117]. For example, one study found that more masculine college students were more likely to intend to do SSE if they received a worry control versus a response-efficacy (i.e., screening can detect skin cancer when it’s most treatable) message [115]. Studies have found barriers to healthcare utilization and prevention among men that may be related to a stereotypical masculine identity including discomfort with communication, feelings of vulnerability or invincibility, and even homophobia [111]. Thus, interventions for men should emphasize “masculine norms” such as self-reliance, emotional control, and power [109]. A few European and Australian interventions targeting middle-aged and older men included male celebrity modeling, use of photos, a website, free exams, and education and were successful in increasing SSE [114], [118], [119] and TCE [120]-[122]. Geller and colleagues (2006) also recommend a national survey to assess men for risk factors, perceived susceptibility, attitudes toward TCE and SSE, perceived barriers, and potential social supports [113].

Figure 1.

Adjusted predicted value (%) for having total-body skin examination among US adults, National Health Interview Survey, 2005

7.2. Young adults

Melanoma is the second most common cancer (after lymphomas) in adolescents and adults younger than age 30 in the US [123]. The high rates of melanoma in this age group can likely be explained by high ultraviolet (UV) radiation exposure and low sun protection rates early in life [124], [125]. About one in three adolescents and young adults report intentional sunbathing [126]-[128], and 40-60% of college students have used indoor tanning booths, with higher rates among women [129]-[131]. In addition, sunscreen use is poor in this age group, with 50-85% failing to routinely wear sunscreen when outdoors [132], [133].

Some organizations recommend regular skin cancer screening beginning at 20 years of age [36], [38]. However, results of the 2000 National Health Interview Surveys showed that only 7% of young adults aged 18-29 years had ever received a TCE, down from 11% in 1998 [134]. Physicians tend to neglect young adults as a group that does not need skin cancer detection counseling [135], [136]. In addition, few studies have examined skin exam rates in young adults. Routine skin exams are largely recommended for those at high risk of skin cancer (usually older adults) [8], but the increasing rates of skin cancer in young adults indicates a potential need for culturally-appropriate interventions to increase skin exams in this age group, particularly among high risk populations such as individuals with a family history of skin cancer or indoor tanners. Skin cancer prevention interventions for young adults benefit from a focus on the negative effects on appearance stemming from UV exposure [137], [138]. Similar appearance-oriented interventions to increase skin cancer screening could focus on the effects of biopsies and skin surgeries if skin cancer is not detected early.

7.3. Racial and ethnic minorities

While white individuals are at higher risk for melanoma, non-white individuals tend to be diagnosed at later stages and have poorer survival [139], [140]. Specifically, ethnic minorities are 1.96 to 3.01 times more likely to die of melanoma, as compared to Whites of the same age and sex [139], [141], [142]. There are likely biological factors that play a role in this disparity [140]. However, another reason for later detection may be that race/ethnicity may be a proxy for some other demographic factors such as poorer SES, lower education, poorer access to healthcare, linguistic barriers, medical distrust, and occupational hazards such as UV exposure [140]. Though skin cancer rates are lower in racial and ethnic minority groups, they are not immune from this disease. Therefore, efforts should be made by healthcare professionals to educate these groups regarding their risk and signs of skin cancer.

Few studies have been conducted to determine the prevalence of TCE and SSE among racial and ethnic minority groups. One study found the rate for ever having had a TCE in Hispanic Whites was 3.7%, compared to 8.9% in non-Hispanic Whites [134]. Another study found rates of 16.2% in Blacks and 17.1% in Hispanics for regularly receiving TCE, compared to 25.5% of Whites [14]3. A study of US university students found that 7.7% of Asian, 12.5% of Black, and 14.3% of Hispanic students reported ever having performed SSE (compared to 39.5% of White students) [144]. A study conducted by Pipitone and colleagues (2002) compared SSE in 27 Hispanic and 113 White individuals, finding that none of the 27 Hispanics reported ever being taught SSE [145]. In addition, the Hispanics reported not being told to perform SSE as often as non-Hispanics were.

7.4. Other underserved populations

Particular attention to underserved populations (e.g., based on education, older age, rural/urban status, etc.) is needed. Demographic variables found to increase prevalence and/or severity of melanoma include urban residence in some cases, lower educational level, not being married, and being retired [31], [47], [146], [147]. TCE rates have been found to be lower among some demographic groups such as non-whites [59], individuals with high occupational UV exposure or lack of health insurance [148], lower educational levels [70], [148], unmarried men [70], and men living in metropolitan areas [114]. Rates of SSE have also been found to be higher among dermatology clinic patients and in younger adults as opposed to adults older than 50 [48], [60], [106]. Skin examination behaviors are influenced by factors such as skin cancer awareness, socio-economic status, and sociocultural values. Perceived risk for and knowledge regarding skin cancer is poor, especially among blacks and those with lower education levels [149]-[153]. Analysis of results from the Health Information National Trends Survey also showed that Blacks, the elderly, and people with less education all perceived themselves as being at reduced risk for skin cancer [149]. Furthermore, these groups, along with Hispanics, tended to believe that they could not reduce their skin cancer risk or that recommendations for risk reduction were too unclear for them to adopt appropriate strategies [149]. Interventions designed to address health disparities should be culturally appropriate, inexpensive, easy to use, be appropriate for low health literacy levels, easily disseminated, address access to care, utilize tailoring, and involve the community when possible [113], [154]-[158]. Additionally, when developing interventions for an older population, it is important to keep in mind declines in cognitive abilities and a reliance on affective decision making as a result of such declines [159], [160].


8. Conclusion

Skin cancer is common and increasing in incidence. Skin cancer screening is efficacious and cost-effective in detecting more curable skin cancers. However, engagement in skin cancer screening is relatively low, even among high risk populations. Thus, research indicates a need for improved skin cancer screening interventions especially among high risk populations such as individuals with a personal or family history of skin cancer and older men. Several behavioral interventions have been developed and have demonstrated some promise in increasing skin cancer exams. However, health disparities in melanoma incidence, morbidity, and mortality exist as well as disparities in engagement in skin cancer detection. These disparities indicate a need for sensitive and culturally-appropriate behavioral interventions. Researchers should attend to individuals with low health literacy levels when designing these interventions. Young adults should also be educated regarding their risk for skin cancer and how to do skin exams, given the increasing rates of skin cancer in this age group. Future research on skin exams might benefit from the incorporation of new technology, such as use of smartphones and other wireless devices. Such approaches might enhance needed dissemination of efficacious interventions to the public.



The authors would like to thank Ms. Jeanne Pomenti, BS and Ms. Alexa Steuer for their assistance with the preparation of this chapter.


  1. 1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006. Archives of Dermatology 2010; 146(3) 283-287.
  2. 2. American Cancer Society. Skin Cancer:Basal and Squamous Cell. 2012 [cited 2012 August 1]; Available from:
  3. 3. Donaldson MR, Coldiron BM. No End in Sight: The Skin Cancer Epidemic Continues. Seminars in Cutaneous Medicine and Surgery 2011; 30(1) 3-5.
  4. 4. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing Burden of Melanoma in the United States. Journal of Investigative Dermatology 2009; 129(7) 1666-1674.
  5. 5. Baxter AJ, Hughes MC, Kvaskoff M, Siskind V, Shekar S, Aitken JF, et al. The Queensland Study of Melanoma: Environmental and Genetic Associations (Q-Mega); Study Design, Baseline Characteristics, and Repeatability of Phenotype and Sun Exposure Measures. Twin Research and Human Genetics 2008; 11(2) 183-196.
  6. 6. Centers for Disease Control and Prevention. Skin Cancer: Risk Factors. 2011 [cited 2012 July 30]; Available from:
  7. 7. Chuang TY, Brashear R. Risk Factors of Non-Melanoma Skin Cancer in United States Veterans Patients: A Pilot Study and Review of Literature. Journal of the European Academy of Dermatology and Venereology 1999; 12(2) 126-132.
  8. 8. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk Factors for Presumptive Melanoma in Skin Cancer Screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program Experience 2001-2005. Journal of the American Academy of Dermatology 2007; 57(1) 60-66.
  9. 9. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, et al. Naevi and Pigmentary Characteristics as Risk Factors for Melanoma in a High-Risk Population: A Case-Control Study in New South Wales, Australia. International Journal of Cancer 1996; 67(4) 485-491.
  10. 10. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis. Mayo Clinic Proceedings 2007; 82(3) 364-380.
  11. 11. Oberyszyn TM. Non-Melanoma Skin Cancer: Importance of Gender, Immunosuppressive Status and Vitamin D. Cancer Letters 2008; 261(2) 127-136.
  12. 12. Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, et al. Nonmelanoma Skin Cancer in Survivors of Childhood and Adolescent Cancer: A Report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology 2005; 23(16) 3733-3741.
  13. 13. Psaty EL, Scope A, Halpern AC, Marghoob AA. Defining the Patient at High Risk for Melanoma. International Journal of Dermatology 2010; 49(4) 362-376.
  14. 14. Qureshi AA, Zhang M, Han J. Heterogeneity in Host Risk Factors for Incident Melanoma and Non-Melanoma Skin Cancer in a Cohort of Us Women. Journal of Epidemiology 2011; 21(3) 197-203.
  15. 15. Siskind V, Aitken J, Green A, Martin N. Sun Exposure and Interaction with Family History in Risk of Melanoma, Queensland, Australia. International Journal of Cancer 2002; 97(1) 90-95.
  16. 16. Armstrong BK, Kricker A. How Much Melanoma Is Caused by Sun Exposure? Melanoma Research 1993; 3(6) 395-401.
  17. 17. Dusza SW, Halpern AC, Satagopan JM, Oliveria SA, Weinstock MA, Scope A, et al. Prospective Study of Sunburn and Sun Behavior Patterns During Adolescence. Pediatrics 2012; 129(2) 309-317.
  18. 18. Lazovich D, Vogel RI, Berwick M, Weinstock M, Anderson KE, Warshaw EM. Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population. Cancer Epidemiology, Biomarkers and Prevention 2010; 19(6) 1557-1568.
  19. 19. Skin Cancer Foundation. Preventing Skin Cancer. 2012 [cited 2012 July 31]; Available from:
  20. 20. Swerdlow AJ, Weinstock MA. Do Tanning Lamps Cause Melanoma? An Epidemiologic Assessment. Journal of the American Academy of Dermatology 1998; 38(1) 89-98.
  21. 21. Vishvakarman D, Wong JC. Description of the Use of a Risk Estimation Model to Assess the Increased Risk of Non-Melanoma Skin Cancer among Outdoor Workers in Central Queensland, Australia. Photodermatology, Photoimmunology & Photomedicine 2003; 19(2) 81-88.
  22. 22. Bruce AJ, Brodland DG. Overview of Skin Cancer Detection and Prevention for the Primary Care Physician. Mayo Clinic Proceedings 2000; 75(5) 491-500.
  23. 23. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic Accuracy of Dermoscopy. Lancet Oncology 2002; 3(3) 159-165.
  24. 24. Rigel DS. Is the Ounce of Screening and Prevention for Skin Cancer Worth the Pound of Cure? CA: A Cancer Journal for Clinicians 1998; 48(4) 236-238.
  25. 25. Aitken JF, Elwood M, Baade PD, Youl P, English D. Clinical Whole-Body Skin Examination Reduces the Incidence of Thick Melanomas. International Journal of Cancer 2010; 126(2) 450-458.
  26. 26. Masri GD, Clark Jr WH, Guerry D, Halpern A, Thompson CJ, Elder DE. Screening and Surveillance of Patients at High Risk for Malignant Melanoma Result in Detection of Earlier Disease. Journal of the American Academy of Dermatology 1990; 22(6, Part 1) 1042-1048.
  27. 27. Pollitt RA, Geller AC, Brooks DR, Johnson TM, Park ER, Swetter SM. Efficacy of Skin Self-Examination Practices for Early Melanoma Detection. Cancer Epidemiology, Biomarkers and Prevention 2009; 18(11) 3018-3023.
  28. 28. Rossi CR, Vecchiato A, Bezze G, Mastrangelo G, Montesco MC, Mocellin S, et al. Early Detection of Melanoma: An Educational Campaign in Padova, Italy. Melanoma Research 2000; 10(2) 181-187.
  29. 29. Schneider JS, Moore DH, 2nd, Mendelsohn ML. Screening Program Reduced Melanoma Mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. Journal of the American Academy of Dermatology 2008; 58(5) 741-749.
  30. 30. Shore RN, Shore P, Monahan NM, Sundeen J. Serial Screening for Melanoma: Measures and Strategies That Have Consistently Achieved Early Detection and Cure. Journal of Drugs in Dermatology : JDD 2011; 10(3) 244-252.
  31. 31. Youl PH, Baade PD, Parekh S, English D, Elwood M, Aitken JF. Association between Melanoma Thickness, Clinical Skin Examination and Socioeconomic Status: Results of a Large Population-Based Study. International Journal of Cancer 2011; 128(9) 2158-2165.
  32. 32. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is Physician Detection Associated with Thinner Melanomas? Journal of the American Medical Association 1999; 281(7) 640-643.
  33. 33. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow Depth of Cutaneous Melanoma: Impact of Factors Related to Surveillance of the Skin, Including Prior Skin Biopsies and Family History of Melanoma. Journal of the American Academy of Dermatology 2005; 53(3) 393-406.
  34. 34. Kantor J, Kantor DE. Routine Dermatologist-Performed Full-Body Skin Examination and Early Melanoma Detection. Archives of Dermatology 2009; 145(8) 873-876.
  35. 35. Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clinical Outcomes from Skin Screening Clinics within a Community-Based Melanoma Screening Program. Journal of the American Academy of Dermatology 2006; 54(1) 105-114.
  36. 36. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2011. Atlanta, GA: American Cancer Society; 2011.
  37. 37. American College of Obstetricians and Gynecologists. Acog Committee Opinion. Primary and Preventive Care: Periodic Assessments. Obstetrics and Gynecology 2003; 102(5 Pt 1)) 1117-1124.
  38. 38. National Cancer Institute. Skin Cancer Screening. 2005 [cited 2012 July 31]; Available from:
  39. 39. American Academy of Dermatology. Be Sun Smart 2010 [cited 2010 April 20, ]; Available from:
  40. 40. U.S. Preventive Services Task Force. Screening for Skin Cancer: Recommendation Statement. 2009 [cited 2012 July 30]; Available from:
  41. 41. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, et al. Multivariate Analysis of Prognostic Factors among 2,313 Patients with Stage Iii Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases. Journal of Clinical Oncology 2010; 28(14) 2452-2459.
  42. 42. Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J, et al. Patterns of Detection in Patients with Cutaneous Melanoma. Cancer 2000; 89(2) 342-347.
  43. 43. Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in Patients with Localised Primary Cutaneous Melanoma. Lancet Oncology 2005; 6(8) 608-621.
  44. 44. Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines. Annals of Surgical Oncology 2007; 14(6) 1924-1933.
  45. 45. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who Discovers Melanoma? Patterns from a Population-Based Survey. Journal of the American Academy of Dermatology 1992; 26(6) 914-919.
  46. 46. Rigel DS, Friedman RJ, Kopf AW, Polsky D. ABCDE--an Evolving Concept in the Early Detection of Melanoma. Archives of Dermatology 2005; 141(8) 1032-1034.
  47. 47. Geller AC, Swetter SM. Reporting and Registering Nonmelanoma Skin Cancers: A Compelling Public Health Need. British Journal of Dermatology 2012; 166(5) 913-915.
  48. 48. Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M. Evaluation of Factors Associated with Skin Self-Examination. Cancer Epidemiology, Biomarkers and Prevention 1999; 8(11) 971-978.
  49. 49. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for Cutaneous Melanoma by Skin Self-Examination. Journal of the National Cancer Institute 1996; 88(1) 17-23.
  50. 50. Housman TS, Williford PM, Feldman SR, Teuschler HV, Fleischer AB, Jr., Goldman ND, et al. Nonmelanoma Skin Cancer: An Episode of Care Management Approach. Dermatologic Surgery 2003; 29(7) 700-711.
  51. 51. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-Effectiveness of Screening for Colorectal Cancer in the General Population. Journal of the American Medical Association 2000; 284(15) 1954-1961.
  52. 52. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK. Screening for Malignant Melanoma: A Cost-Effectiveness Analysis. Journal of the American Academy of Dermatology 1999; 41(5) 738-745.
  53. 53. Losina E, Walensky RP, Geller A, Beddingfield FC, III, Wolf LL, Gilchrest BA, et al. Visual Screening for Malignant Melanoma: A Cost-Effectiveness Analysis. Archives of Dermatology 2007; 143(1) 21-28.
  54. 54. Salzmann P, Kerlikowske K, Phillips K. Cost-Effectiveness of Extending Screening Mammography Guidelines to Include Women 40 to 49 Years of Age. Annals of Internal Medicine 1997; 127(11) 955-965.
  55. 55. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for Melanoma by Primary Health Care Physicians: A Cost-Effectiveness Analysis. Journal of Medical Screening 1996; 3(1) 47-53.
  56. 56. Beland D, Waddan A. The Obama Presidency and Health Insurance Reform: Assessing Continuity and Change. Social Policy and Society 2012; 11(3) 319-330.
  57. 57. Albright HW, Moreno M, Feeley TW, Walters R, Samuels M, Pereira A, et al. The Implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on Cancer Care Delivery. Cancer 2011; 117(8) 1564-1574.
  58. 58. Coups EJ, Geller AC, Weinstock MA, Heckman CJ, Manne SL. Prevalence and Correlates of Skin Cancer Screening among Middle-Aged and Older White Adults in the United States. American Journal of Medicine 2010; 123(5) 439-445.
  59. 59. Lakhani NA, Shaw KM, Thompson T, Yaroch AL, Glanz K, Hartman AM, et al. Prevalence and Predictors of Total-Body Skin Examination among Us Adults: 2005 National Health Interview Survey. Journal of the American Academy of Dermatology 2011; 65(3) 645-648.
  60. 60. Aitken JF, Youl PH, Janda M, Elwood M, Ring IT, Lowe JB, et al. Validity of Self-Reported Skin Screening Histories. American Journal of Epidemiology 2004; 159(11) 1098-1105.
  61. 61. Douglass HM, McGee R, Williams S. Are Young Adults Checking Their Skin for Melanoma? Australian and New Zealand Journal of Public Health 1998; 22(5) 562-567.
  62. 62. Friedman LC, Bruce S, Webb JA, Weinberg AD, Cooper HP. Skin Self-Examination in a Population at Increased Risk for Skin Cancer. American Journal of Preventive Medicine 1993; 9(6) 359-364.
  63. 63. Girgis A, Campbell EM, Redman S, Sanson-Fisher RW. Screening for Melanoma: A Community Survey of Prevalence and Predictors. Medical Journal of Australia 1991; 154(5) 338-343.
  64. 64. Kasparian NA, McLoone JK, Meiser B. Skin Cancer-Related Prevention and Screening Behaviors: A Review of the Literature. Journal of Behavioral Medicine 2009; 32(5) 406-428.
  65. 65. Robinson JK, Rigel DS, Amonette RA. What Promotes Skin Self-Examination? Journal of the American Academy of Dermatology 1998; 39752-757.
  66. 66. Weinstock MA, Martin RA, Risica PM, Berwick M, Lasater T, Rakowski W, et al. Thorough Skin Examination for the Early Detection of Melanoma. American Journal of Preventive Medicine 1999; 17(3) 169-175.
  67. 67. MacKie RM, Bray CA, Leman JA. Effect of Public Education Aimed at Early Diagnosis of Malignant Melanoma: Cohort Comparison Study. British Medical Journal 2003; 326(7385) 367.
  68. 68. Oliveria SA, Heneghan MK, Cushman LF, Ughetta EA, Halpern AC. Skin Cancer Screening by Dermatologists, Family Practitioners, and Internists: Barriers and Facilitating Factors. Archives of Dermatology 2011; 147(1) 39-44.
  69. 69. Janda M, Elwood M, Ring IT, Firman DW, Lowe JB, Youl PH, et al. Prevalence of Skin Screening by General Practitioners in Regional Queensland. Medical Journal of Australia 2004; 180(1) 10-15.
  70. 70. Coups EJ, Manne SL, Jacobsen PB, Ming ME, Heckman CJ, Lessin SR. Skin Surveillance Intentions among Family Members of Patients with Melanoma. BMC Public Health 2011; 11866-891.
  71. 71. Douglas NC, Baillie L, Soyer HP. Skin Cancer Screening of Outdoor Workers in Queensland. Medical Journal of Australia 2011; 195(2) 100-101.
  72. 72. Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, et al. Sun Protection and Skin Self-Examination in Melanoma Survivors. Psycho-Oncology 2009; 18(10) 1106-1115.
  73. 73. Manne S, Lessin S. Prevalence and Correlates of Sun Protection and Skin Self-Examination Practices among Cutaneous Malignant Melanoma Survivors. Journal of Behavioral Medicine 2006; 29(5) 419-434.
  74. 74. Mesters I, Jonkman L, Vasen H, de Vries H. Skin Self-Examination of Persons from Families with Familial Atypical Multiple Mole Melanoma (Fammm). Patient Education and Counseling 2009; 75(2) 251-255.
  75. 75. Phelan DL, Oliveria SA, Christos PJ, Dusza SW, Halpern AC. Skin Self-Examination in Patients at High Risk for Melanoma: A Pilot Study. Oncology Nursing Forum 2003; 30(6) 1029-1036.
  76. 76. Garside R, Pearson M, Moxham T. What Influences the Uptake of Information to Prevent Skin Cancer? A Systematic Review and Synthesis of Qualitative Research. Health Education Research 2010; 25(1) 162-182.
  77. 77. Geller AC, Swetter SM, Brooks K, Demierre M-F, Yaroch AL. Screening, Early Detection, and Trends for Melanoma: Current Status (2000-2006) and Future Directions. Journal of the American Academy of Dermatology 2007; 57(4) 555-572.
  78. 78. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A Randomised Trial of Population Screening for Melanoma. Journal of Medical Screening 2002; 9(1) 33-37.
  79. 79. Lowe JB, Ball J, Lynch BM, Baldwin L, Janda M, Stanton WR, et al. Acceptability and Feasibility of a Community-Based Screening Programme for Melanoma in Australia. Health Promotion International 2004; 19(4) 437-444.
  80. 80. Youl PH, Janda M, Elwood M, Lowe JB, Ring IT, Aitken JF. Who Attends Skin Cancer Clinics within a Randomized Melanoma Screening Program? Cancer Detection and Prevention 2006; 30(1) 44-51.
  81. 81. Friedman LC, Webb JA, Bruce S, Weinberg AD, Cooper HP. Skin Cancer Prevention and Early Detection Intentions and Behavior. American Journal of Preventive Medicine 1995; 11(1) 59-65.
  82. 82. Manne S, Jacobsen PB, Ming ME, Winkel G, Dessureault S, Lessin SR. Tailored Versus Generic Interventions for Skin Cancer Risk Reduction for Family Members of Melanoma Patients. Health Psychology 2010; 29(6) 583-593.
  83. 83. Carmel S, Shani E, Rosenberg L. The Role of Age and an Expanded Health Belief Model in Predicting Skin Cancer Protective Behavior. Health Education Research 1994; 9(4) 433-447.
  84. 84. Kundu RV, Kamaria M, Ortiz S, West DP, Rademaker AW, Robinson JK. Effectiveness of a Knowledge-Based Intervention for Melanoma among Those with Ethnic Skin. Journal of the American Academy of Dermatology 2010; 62(5) 777-784.
  85. 85. Lee KB, Weinstock MA, Risica PM. Components of a Successful Intervention for Monthly Skin Self-Examination for Early Detection of Melanoma: The "Check It out" Trial. Journal of the American Academy of Dermatology 2008; 58(6) 1006-1012.
  86. 86. Weinstock MA, Risica PM, Martin RA, Rakowski W, Dube C, Berwick M, et al. Melanoma Early Detection with Thorough Skin Self-Examination: The "Check It out" Randomized Trial. American Journal of Preventive Medicine 2007; 32(6) 517-524.
  87. 87. Mickler TJ, Rodrigue JR, Lescano C. A Comparison of Three Methods of Teaching Skin Self-Examinations. Journal of Clinical Psychology in Medical Settings 1999; 6(3) 273-286.
  88. 88. Aneja S, Brimhall AK, Kast DR, Carlson D, Cooper KD, Bordeaux JS. Improvement in Patient Performance of Skin Self-Examinations after Intervention with Interactive Education and Telecommunication Reminders: A Randomized Controlled Study. Archives of Dermatology 2012; 1-7.
  89. 89. Glazebrook C, Garrud P, Avery A, Coupland C, Williams H. Impact of a Multimedia Intervention "Skinsafe" on Patients' Knowledge and Protective Behaviors. Preventive medicine 2006; 42(6) 449-454.
  90. 90. Berwick M, Oliveria S, Luo ST, Headley A, Bolognia JL. A Pilot Study Using Nurse Education as an Intervention to Increase Skin Self-Examination for Melanoma. Journal of Cancer Education 2000; 15(1) 38-40.
  91. 91. Edmondson PC, Curley RK, Marsden RA, Robinson D, Allaway SL, Willson CD. Screening for Malignant Melanoma Using Instant Photography. Journal of Medical Screening 1999; 6(1) 42-46.
  92. 92. Glanz K, Schoenfeld ER, Steffen A. A Randomized Trial of Tailored Skin Cancer Prevention Messages for Adults: Project Scape. American Journal of Public Health 2010; 100(4) 735-741.
  93. 93. Loescher LJ, Hibler E, Hiscox H, Quale L, Harris R. An Internet-Delivered Video Intervention for Skin Self-Examination by Patients with Melanoma. Archives of Dermatology 2010; 146(8) 922-923.
  94. 94. Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC. Patient Adherence to Skin Self-Examination. Effect of Nurse Intervention with Photographs. American Journal of Preventive Medicine 2004; 26(2) 152-155.
  95. 95. Weinstock MA, Nguyen FQ, Martin RA. Enhancing Skin Self-Examination with Imaging: Evaluation of a Mole-Mapping Program. Journal of Cutaneous Medicine and Surgery 2004; 8(1) 1-5.
  96. 96. Robinson JK, Turrisi R, Stapleton J. Efficacy of a Partner Assistance Intervention Designed to Increase Skin Self-Examination Performance. Archives of Dermatology 2007a; 143(1) 37-41.
  97. 97. Robinson JK, Turrisi R, Stapleton J. Examination of Mediating Variables in a Partner Assistance Intervention Designed to Increase Performance of Skin Self-Examination. Journal of the American Academy of Dermatology 2007b; 56(3) 391-397.
  98. 98. Boone SL, Stapleton J, Turrisi R, Ortiz S, Robinson JK, Mallett KA. Thoroughness of Skin Examination by Melanoma Patients: Influence of Age, Sex and Partner. Australasian Journal of Dermatology 2009; 50(3) 176-180.
  99. 99. Robinson JK, Turrisi R, Mallett K, Stapleton J, Boone SL, Kim N, et al. Efficacy of an Educational Intervention with Kidney Transplant Recipients to Promote Skin Self-Examination for Squamous Cell Carcinoma Detection. Archives of Dermatology 2011; 147(6) 689-695.
  100. 100. Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, et al. Superior Outcome of Women with Stage I/Ii Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase Iii Trials. Journal of Clinical Oncology 2012; 30(18) 2240-2247.
  101. 101. Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AM, Holzel D, et al. Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis. Journal of Investigative Dermatology 2011; 131(3) 719-726.
  102. 102. iegel R, Ward E, Brawley O, Jemal A. Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths. CA: A Cancer Journal for Clinicians 2011; 61(4) 212-236.
  103. 103. Tuong W, Cheng LS, Armstrong AW. Melanoma: Epidemiology, Diagnosis, Treatment, and Outcomes. Dermatologic Clinics 2012; 30(1) 113-124, ix.
  104. 104. Balanda KP, Lowe JB, Stanton WR, Gillespie AM. Enhancing the Early Detection of Melanoma within Current Guidelines. Australian Journal of Public Health 1994; 18(4) 420-423.
  105. 105. Federman DG, Kravetz JD, Ma F, Kirsner RS. Patient Gender Affects Skin Cancer Screening Practices and Attitudes among Veterans. Southern Medical Journal 2008; 101(5) 513-518.
  106. 106. Robinson JK, Fisher SG, Turrisi RJ. Predictors of Skin Self-Examination Performance. Cancer 2002; 95(1) 135-146.
  107. 107. Swetter SM, Layton CJ, Johnson TM, Brooks KR, Miller DR, Geller AC. Gender Differences in Melanoma Awareness and Detection Practices between Middle-Aged and Older Men with Melanoma and Their Female Spouses. Archives of Dermatology 2009; 145(4) 488-490.
  108. 108. Janda M, Youl PH, Lowe JB, Elwood M, Ring IT, Aitken JF. Attitudes and Intentions in Relation to Skin Checks for Early Signs of Skin Cancer. Preventive Medicine 2004; 39(1) 11-18.
  109. 109. Addis ME, Mahalik JR. Men, Masculinity, and the Contexts of Help Seeking. American Psychologist 2003; 58(1) 5-14.
  110. 110. Conway M, Dube L. Humor in Persuasion on Threatening Topics: Effectiveness Is a Function of Audience Sex Role Orientation. Personality and Social Psychology Bulletin 2002; 28(7) 863-873.
  111. 111. Galdas PM, Cheater F, Marshall P. Men and Health Help-Seeking Behaviour: Literature Review. Journal of Advanced Nursing 2005; 49(6) 616-623.
  112. 112. Geller AC, Sober AJ, Zhang Z, Brooks DR, Miller DR, Halpern A, et al. Strategies for Improving Melanoma Education and Screening for Men Age >or= 50 Years: Findings from the American Academy of Dermatological National Skin Cancer Sreening Program. Cancer 2002; 95(7) 1554-1561.
  113. 113. Geller J, Swetter SM, Leyson J, Miller DR, Brooks K, Geller AC. Crafting a Melanoma Educational Campaign to Reach Middle-Aged and Older Men. Journal of Cutaneous Medicine and Surgery 2006; 10(6) 259-268.
  114. 114. Janda M, Baade PD, Youl PH, Aitken JF, Whiteman DC, Gordon L, et al. The Skin Awareness Study: Promoting Thorough Skin Self-Examination for Skin Cancer among Men 50 Years or Older. Contemporary Clinical Trials 2010; 31(1) 119-130.
  115. 115. Millar MG, Houska JA. Masculinity and Intentions to Perform Health Behaviors: The Effectiveness of Fear Control Arguments. Journal of Behavioral Medicine 2007; 30(5) 403-409.
  116. 116. Sabinsky MS, Toft U, Raben A, Holm L. Overweight Men's Motivations and Perceived Barriers Towards Weight Loss. European Journal of Clinical Nutrition 2007; 61(4) 526-531.
  117. 117. Walsh LA, Stock ML. Uv Photography, Masculinity, and College Men's Sun Protection Cognitions. Journal of Behavioral Medicine 2012; 35(4) 431-442.
  118. 118. Barysch MJ, Cozzio A, Kolm I, Hrdlicka SR, Brand C, Hunger R, et al. Internet Based Health Promotion Campaign against Skin Cancer - Results of Www.Skincheck.Ch in Switzerland. European Journal of Dermatology 2010; 20(1) 109-114.
  119. 119. Janda M, Neale RE, Youl P, Whiteman DC, Gordon L, Baade PD. Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-Examination in Men 50 Years or Older: The Randomized Skin Awareness Trial. Archives of Dermatology 2011; 147(7) 799-806.
  120. 120. Del Marmol V, de Vries E, Roseeuw D, Pirard C, van der Endt J, Trakatelli M, et al. A Prime Minister Managed to Attract Elderly Men in a Belgian Euromelanoma Campaign. European Journal of Cancer 2009; 45(9) 1532-1534.
  121. 121. Hanrahan PF, D'Este CA, Menzies SW, Plummer T, Hersey P. A Randomised Trial of Skin Photography as an Aid to Screening Skin Lesions in Older Males. Journal of Medical Screening 2002; 9(3) 128-132.
  122. 122. Hanrahan PF, Menzies SW, D'Este CA, Plummer T, Hersey P. Participation of Older Males in a Study on Photography as an Aid to Early Detection of Melanoma. Australian and New Zealand Journal of Public Health 2000; 24(6) 615-618.
  123. 123. Bleyer A, Viny A, Barr R. Cancer in 15- to 29-Year-Olds by Primary Site. Oncologist 2006; 11(6) 590-601.
  124. 124. Olson AL, Starr P. The Challenge of Intentional Tanning in Teens and Young Adults. Dermatologic Clinics 2006; 24(2) 131-136.
  125. 125. Stanton WR, Janda M, Baade PD, Anderson P. Primary Prevention of Skin Cancer: A Review of Sun Protection in Australia and Internationally. Health Promotion International 2004; 19(3) 369-378.
  126. 126. Cokkinides VE, Weinstock MA, O'Connell MC, Thun MJ. Use of Indoor Tanning Sunlamps by Us Youth, Ages 11-18 Years, and by Their Parent or Guardian Caregivers: Prevalence and Correlates. Pediatrics 2002; 109(6) 1124-1130.
  127. 127. Dennis LK, Kancherla V, Snetselaar L. Adolescent Attitudes Towards Tanning: Does Age Matter? Pediatric Health 2009; 3(6) 565-578.
  128. 128. Stryker JE, Lazovich D, Forster JL, Emmons KM, Sorensen G, Demierre MF. Maternal/Female Caregiver Influences on Adolescent Indoor Tanning. Journal of Adolescent Health 2004; 35(6) 528 e521-529.
  129. 129. Gibbons FX, Gerrard M, Lane DJ, Mahler HI, Kulik JA. Using Uv Photography to Reduce Use of Tanning Booths: A Test of Cognitive Mediation. Health Psychology 2005; 24(4) 358-363.
  130. 130. Hillhouse J, Stapleton J, Turrisi R. Association of Frequent Indoor Uv Tanning with Seasonal Affective Disorder. Archives of Dermatology 2005; 141(11) 1465.
  131. 131. Poorsattar SP, Hornung RL. Uv Light Abuse and High-Risk Tanning Behavior among Undergraduate College Students. Journal of the American Academy of Dermatology 2007; 56(3) 375-379.
  132. 132. Cokkinides V, Weinstock M, Lazovich D, Ward E, Thun M. Indoor Tanning Use among Adolescents in the Us, 1998 to 2004. Cancer 2009; 115(1) 190-198.
  133. 133. Jones SE, Saraiya M, Miyamoto J, Berkowitz Z. Trends in Sunscreen Use among U.S. High School Students: 1999-2009. Journal of Adolescent Health 2012; 50(3) 304-307.
  134. 134. Saraiya M, Hall HI, Thompson T, Hartman A, Glanz K, Rimer BK, et al. Skin Cancer Screening among U.S. Adults from 1992, 1998, and 2000 National Health Interview Surveys. Preventive Medicine 2004; 39(2) 308-314.
  135. 135. Feldman SR, Fleischer AB, Jr. Skin Examinations and Skin Cancer Prevention Counseling by Us Physicians: A Long Way to Go. Journal of the American Academy of Dermatology 2000; 43(2 Pt 1) 234-237.
  136. 136. Gritz ER, Tripp MK, de Moor CA, Eicher SA, Mueller NH, Spedale JH. Skin Cancer Prevention Counseling and Clinical Practices of Pediatricians. Pediatric Dermatology 2003; 20(1) 16-24.
  137. 137. Hillhouse J, Turrisi R, Stapleton J, Robinson J. A Randomized Controlled Trial of an Appearance-Focused Intervention to Prevent Skin Cancer. Cancer 2008; 113(11) 3257-3266.
  138. 138. Mahler HI, Kulik JA, Gibbons FX, Gerrard M, Harrell J. Effects of Appearance-Based Interventions on Sun Protection Intentions and Self-Reported Behaviors. Health Psychology 2003; 22(2) 199-209.
  139. 139. Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Ethnic Differences among Patients with Cutaneous Melanoma. Archives of Internal Medicine 2006; 166(17) 1907-1914.
  140. 140. Hernandez C, Mermelstein RJ. A Conceptual Framework for Advancing Melanoma Health Disparities Research. Archives of Dermatology 2009; 145(12) 1442-1446.
  141. 141. Byrd-Miles K, Toombs EL, Peck GL. Skin Cancer in Individuals of African, Asian, Latin-American, and American-Indian Descent: Differences in Incidence, Clinical Presentation, and Survival Compared to Caucasians. Journal of Drugs in Dermatology 2007; 6(1) 10-16.
  142. 142. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and Black Americans. Cancer Control 2008; 15(3) 248-253.
  143. 143. Rodriguez GL, Ma F, Federman DG, Rouhani P, Chimento S, Multach M, et al. Predictors of Skin Cancer Screening Practice and Attitudes in Primary Care. Journal of the American Academy of Dermatology 2007; 57(5) 775-781.
  144. 144. Arnold MR, DeJong W. Skin Self-Examination Practices in a Convenience Sample of U.S. University Students. Preventive Medicine 2005; 40(3) 268-273.
  145. 145. Pipitone M, Robinson JK, Camara C, Chittineni B, Fisher SG. Skin Cancer Awareness in Suburban Employees: A Hispanic Perspective. Journal of the American Academy of Dermatology 2002; 47(1) 118-123.
  146. 146. Coory M, Smithers M, Aitken J, Baade P, Ring I. Urban-Rural Differences in Survival from Cutaneous Melanoma in Queensland. Australian and New Zealand Journal of Public Health 2006; 30(1) 71-74.
  147. 147. Perez-Gomez B, Aragones N, Gustavsson P, Lope V, Lopez-Abente G, Pollan M. Socio-Economic Class, Rurality and Risk of Cutaneous Melanoma by Site and Gender in Sweden. BMC Public Health 2008; 833.
  148. 148. LeBlanc WG, Vidal L, Kirsner RS, Lee DJ, Caban-Martinez AJ, McCollister KE, et al. Reported Skin Cancer Screening of Us Adult Workers. Journal of the American Academy of Dermatology 2008; 59(1) 55-63.
  149. 149. Buster KJ, You Z, Fouad M, Elmets C. Skin Cancer Risk Perceptions: A Comparison across Ethnicity, Age, Education, Gender, and Income. Journal of the American Academy of Dermatology 2012; 66(5) 771-779.
  150. 150. Han PK, Moser RP, Klein WM, Beckjord EB, Dunlavy AC, Hesse BW. Predictors of Perceived Ambiguity About Cancer Prevention Recommendations: Sociodemographic Factors and Mass Media Exposures. Health Communication 2009; 24(8) 764-772.
  151. 151. Hay J, Coups EJ, Ford J, DiBonaventura M. Exposure to Mass Media Health Information, Skin Cancer Beliefs, and Sun Protection Behaviors in a United States Probability Sample. Journal of the American Academy of Dermatology 2009; 61(5) 783-792.
  152. 152. Rutten LF, Hesse BW, Moser RP, McCaul KD, Rothman AJ. Public Perceptions of Cancer Prevention, Screening, and Survival: Comparison with State-of-Science Evidence for Colon, Skin, and Lung Cancer. Journal of Cancer Education 2009; 24(1) 40-48.
  153. 153. Viswanath K, Breen N, Meissner H, Moser RP, Hesse B, Steele WR, et al. Cancer Knowledge and Disparities in the Information Age. Journal of Health Communication 2006; 11 Suppl 11-17.
  154. 154. Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD. African-American Men's Perceptions About Prostate Cancer: Implications for Designing Educational Interventions. Social Science & Medicine 2007; 64(11) 2189-2200.
  155. 155. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, et al. Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults: A Scientific Statement from the American Heart Association. Circulation 2010; 122(4) 406-441.
  156. 156. Cooper LA, Hill MN, Powe NR. Designing and Evaluating Interventions to Eliminate Racial and Ethnic Disparities in Health Care. Journal of General Internal Medicine 2002; 17(6) 477-486.
  157. 157. Friedman DB, Kao EK. A Comprehensive Assessment of the Difficulty Level and Cultural Sensitivity of Online Cancer Prevention Resources for Older Minority Men. Preventing Chronic Disease 2008; 5(1) A07.
  158. 158. Taylor KL, Turner RO, Davis JL, 3rd, Johnson L, Schwartz MD, Kerner J, et al. Improving Knowledge of the Prostate Cancer Screening Dilemma among African American Men: An Academic-Community Partnership in Washington, Dc. Public Health Reports 2001; 116(6) 590-598.
  159. 159. Finucane TE. More Promotional Rhetoric in Research: The Maryland Assisted Living Study. Journal of the American Geriatrics Society 2008; 56(1) 185; author reply 1185-1186.
  160. 160. Isaacowitz DM, Choi Y. Looking, Feeling, and Doing: Are There Age Differences in Attention, Mood, and Behavioral Responses to Skin Cancer Information? Health Psychology 2012; 31(5) 650-659.

Written By

Carolyn J. Heckman, Susan Darlow, Teja Munshi and Clifford Perlis

Submitted: May 8th, 2012 Published: April 17th, 2013